Evogene Ltd. - Ordinary Shares (EVGN)
2.2600
+1.1300 (100.00%)
NASDAQ · Last Trade: Jun 10th, 6:26 PM EDT
Detailed Quote
Previous Close | 1.130 |
---|---|
Open | 2.080 |
Bid | 2.050 |
Ask | 2.070 |
Day's Range | 1.760 - 2.420 |
52 Week Range | 0.9500 - 7.190 |
Volume | 102,340,735 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 40,305 |
Chart
About Evogene Ltd. - Ordinary Shares (EVGN)
Evogene Ltd is a biotechnology company focused on enhancing the productivity and sustainability of the agriculture industry through the development of innovative biological solutions. The company leverages advanced computational biology and data-driven approaches to identify and engineer novel traits in plants, aiming to improve crop performance and resilience. By utilizing its proprietary technology platform, Evogene collaborates with industry partners to create products that address critical challenges such as pest resistance, drought tolerance, and nutrient efficiency in various agricultural sectors. Read More
News & Press Releases
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · June 10, 2025
Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company’s FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.
Via AB Newswire · June 10, 2025
Power Metallic Mines Inc. (TSXV: PNPN) (OTCQB: PNPNF) has executed a deal to acquire 100% of 313 mineral claims from Li-FT Power Ltd., expanding its Quebec land position by over 300% to 212.86 km² . The newly acquired claims border the Company’s flagship Nisk Project, surrounding the high-grade Nisk, Lion, and Tiger polymetallic discoveries.
Via AB Newswire · June 10, 2025
Via Benzinga · June 10, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · June 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · June 10, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · June 10, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill · April 22, 2025
As markets navigate continued volatility, several stocks have entered oversold territory—presenting potential opportunity for value-seeking investors. Below are fast takes on notable names, including Evogene Ltd. (NASDAQ: EVGN), Gulf Resources Inc. (NASDAQ: GURE), Peraso Inc. (NASDAQ: PRSO), MicroAlgo Inc. (NASDAQ: MLGO) and more across biotech, fintech, and industrial segments among others below.
Via AB Newswire · April 22, 2025
Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals.
Via Benzinga · April 21, 2025

EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 22, 2024

EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 23, 2024

EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024

Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported $5.6 million in total revenue for the year. CEO Ofer Haviv highlighted the company's successful collaborations with industry leaders like Corteva, ICL, and Syngenta, contributing to revenue growth. In Q4, gross profit decreased to $180,000, but net financing income rose to $287,000. Total operating expenses increased to $7.8 million, leading to a net loss of $7.3 million. For the full year, gross profit reached $3.9 million, and net financing income was approximately $521,000. Evogene also secured partnerships with Verb Biotics and Colors Farm, along with receiving a €1.2 million EU grant for its Ag-Seed Division's research and development efforts.
Via Benzinga · March 7, 2024

Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech.
Via Benzinga · November 16, 2023

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024